MaxCyte logo

MaxCyte

MXCT | NASDAQ
Chart Builder DCF Calculator
$1.18
-$0.01 (-0.84%)
At close: Nov 16, 2026, 4:00 PM ET
$1.18
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:15 PM ET
-0.84%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
48.8
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #312/1021 (Top 31%)

Key Statistics

Market Data

Market Cap $121.84M
1D Range
1.15 1.28
52W Range
0.68 1.76

Valuation (TTM)

PE -4.54
PB 0.81
EV/EBITDA -1.59

Valuation (NTM)

Forward PE N/A
Forward PEG 0.13
Price Target $4.00
Loading financial charts...

Profile

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static elec...

Sector Healthcare
Industry Biotechnology
Employees 91
IPO Date Jul 29, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$0.05
Beat +35.48%
REV
$10.15M
Beat +37.35%
Next Earnings
Mar 16, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$4.00
Upside
+238.98%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.